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Abstract
Due to the limited self-repair capacity of cartilage, regenerative medicine therapies for the treatment
of cartilage defects must use a signiﬁcant amount of cells, preferably applied using a hydrogel system
that can promise their delivery and functionality at the speciﬁc site. This paper discusses the potential
use of k-carrageenan hydrogels for the delivery of stem cells obtained from adipose tissue in the
treatment of cartilage tissue defects. The developed hydrogels were produced by an ionotropic
gelationmethod and human adipose stem cells (hASCs) were encapsulated in 1.5%w/v k-carrageenan
solution at a cell density of 5106 cells/ml. The results from the analysis of the cell-encapsulating
hydrogels, cultured for up to 21days, indicated that k-carrageenan hydrogels support the viability,
proliferation and chondrogenic differentiation of hASCs. Additionally, the mechanical analysis
demonstrated an increase in stiffness and viscoelastic properties of k-carrageenan gels with their
encapsulated cells with increasing time in culture with chondrogenic medium. These results allowed
the conclusion that k-carrageenan exhibits properties that enable the in vitro functionality of
encapsulated hASCs and thus may provide the basis for new successful approaches for the treatment
of cartilage defects. Copyright © 2013 John Wiley & Sons, Ltd.
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1. Introduction
The need for tissue-engineered cartilage constructs is im-
mense and of great clinical signiﬁcance, because no existing
medication or surgical procedures substantially promotes
the healing process of articular cartilage. Compared to other
connective tissues, cartilage is an avascular, aneural tissue,
consisting of relatively few cells, proteoglycans and
proteins, and thus, when damaged due to a degenerative
disease or trauma, the functional and the metabolic
properties of the original hyaline tissue will hardly ever be
restored (Redman et al., 2005). Cartilage tissue-engineering
approaches, adopting the delivery of an appropriate type
and amount of cells, with or without signalling factors, offer
considerable promise as regeneration strategies (Tuli et al.,
2003; Nesic et al., 2006). However, for further improve-
ment, minimally invasive approaches and innovative cell-
carrier concepts should be reﬁned, using the right
biomaterials and cell sources (Sittinger et al., 2004). Stem
cells are the best chance for human cartilage regeneration,
given their ability to differentiate in vitro in different
lineages, availability and expansion (Vallee et al., 2009).
In particular, adipose tissue has generated signiﬁcant inter-
est in cartilage tissue engineering as an abundant source of
multipotent progenitor cells, which are easily acquired at
high yields and can be obtained from the patient by mini-
mally invasive procedures, such as liposuction (Erickson
et al., 2002; Augst et al., 2006; Tapp et al., 2009). Hydrogels
are the basis of cell-encapsulation systems, one of the most
promising approaches for the delivery of cells and therapeu-
tic agents to the site of interest (Jen et al., 1996; Drury and
Mooney, 2003; Slaughter et al., 2009). Different hydrogels
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have previously been studied for biomedical applications,
such as alginate and agarose (Augst et al., 2006; Varoni
et al., 2012). In the present study we evaluated the potential
use of k-carrageenan hydrogel extracted from red algae as a
cell carrier system. k-Carrageenan is an ionic natural
polysaccharide that displays unique properties that may
provide advantageous features for application in the
tissue-engineering ﬁeld. Carrageenan is composed of large,
highly ﬂexible molecules which curl, forming helical
structures (Bixler, 1994; Sipahigil and Dortunc, 2001),
rendering them able to form a variety of different gels at
room temperature and thus enabling great versatility. The
fully carbohydrate-based hydrogels of alternating copol-
ymers of a-(1-3)-D-galactose and b-(1-4)-3,6-anhydro-D-
or L-galactose (Meunier et al., 2001) are expected to
be biologically compatible, biodegradable and non-toxic.
k-Carrageenan has only one negative charge per disaccharide,
with a tendency to form a strong and rigid gel. Carrageenan
gels in the presence of potassium ions but also has the abil-
ity to form gels under salt-free conditions, being a thermo-
sensitive hydrogel (Lennart, 2006). The mechanism of gel
formation is still under discussion; nevertheless, the ﬁrst
step may well be double helix stabilization when K+ is the
counter-ion (Kara et al., 2003). Because of the ionic
nature of the polymer, the gelling andmelting temperatures
of k-carrageenan are almost solely dependent on the con-
centration of potassium ions (Mangione et al., 2005). Ther-
moreversible gels, such as k-carrageenan, melt at elevated
temperatures, and lowering the temperature results in the
gelation of the biopolymer. The temperature-induced gela-
tion allows for the easy formation of gels in different shapes.
The negative charge permits ionic interactions with mole-
cules such as water or protein and allows a large osmotic
swelling pressure. To some extent, k-carrageenan resembles
naturally occurring glycosaminoglycans, owing to their
backbone composition of sulphated disaccharides
(Velleman, 1999). At present there is little information
about the potential use of k-carrageenan as a new natural
material in biomedical applications. Nevertheless, the
results published to date suggest that k-carrageenan hydro-
gels exhibit comparable biological behaviour to, but higher
mechanical properties than, similar hydrogels extensively
used for tissue-engineering purposes (Awad et al., 2004;
Bosnakovski et al., 2006; Kisiday et al., 2008). The objective
of this study was to develop k-carrageenan hydrogel aimed
at application in cartilage tissue engineering. Therefore, the
swelling and cytotoxicity of the hydrogels were studied, as
well as their ability to sustain the proliferation and chondro-
genic differentiation of hASCs. Furthermore, the mechani-
cal properties of hydrogels with encapsulated hASCs after
different times in culture were also evaluated. The results
obtained demonstrated that k-carrageenan hydrogels are
non-cytotoxic and support the proliferation and chondro-
genic differentiation of encapsulated hASCs. Additionally,
the mechanical properties of the cell-loaded hydrogels are
maintained and even increased with increasing culture
time, suggesting that the proposed systems provides a
promising alternative to current approaches for cartilage
tissue engineering.
2. Materials and methods
2.1. k-Carrageenan hydrogel preparation
An aqueous solution was prepared by dissolving the
k-carrageenan powder (Sigma Fluka) in distilled water,
and heating at 60 C while stirring constantly for 2 h until
complete and homogeneous dispersion of the material
was obtained. Previous to use, the k-carrageenan solution
was autoclaved for 30min at 120 C and prepared just
before use. k-Carrageenan hydrogel samples were produced
using the sterilized polymeric solution with a ﬁnal concen-
tration of 1.5% w/v and 5% w/v potassium chloride (KCl;
Sigma) as a crosslinker reagent. The samples were shaped
in the form of discs, using cylindrical moulds, and a com-
plete gelation carried out for 2–5min at room temperature
to form a solid gel. After gelation, the moulds’ ends were
cut and the cylindrical hydrogels pushed out and
immersed in KCl for 15–30min in order to stabilize the
three-dimensional (3D) structure. Afterwards, the gels
were washed with phosphate-buffered saline (PBS;
Sigma) to remove the excess KCl present in the materials.
Sample discs were then sliced off the hydrogel cylinders,
using a thin sterile blade; disc dimensions were diameter
5 0.01height 2.5 0.46mm. These samples were
used for evaluating the swelling kinetics and cytotoxicity
of the hydrogel.
2.2. k-Carrageenan hydrogel physical
characterization
2.2.1. Swelling kinetics
The swelling kinetics of the developed hydrogels was
studied in a PBS solution (different pH values were
tested) and in culture medium [Dulbecco’s modiﬁed
Eagle’s medium (DMEM), supplemented with fetal bovine
serum (FBS; Gibco]. For this purpose, a weighed amount
of each hydrogel formulation was immersed in each
testing solution (PBS and DMEM, pH 7.4) and incubated
at 37 C under static conditions. The inﬂuence of pH of
the PBS solution on the water uptake of k-carrageenan
hydrogel was also analysed. The swelling ratio was
calculated using Equation 1:




where Ws is the weight of swollen gel after reaching
equilibrium value under speciﬁed environmental conditions
(PBS or DMEM) and Wd is the weight of the dried gel. To
measure Ws, the swollen hydrogels were removed from
the PBS or DMEM and immediately weighed with a micro-
balance after the excess of water lying on the surfaces was
absorbed with a ﬁlter paper. Three samples were used for
each testing condition (n=3).
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2.3. k-Carrageenan hydrogel biological
evaluation
2.3.1. Cytotoxicity screening
The cytotoxicity of the leachable hydrogels was evaluated
using L929 mouse ﬁbroblast cells [European Collection of
Cell Cultures (ECACC), UK], as described elsewhere
(Gomes et al., 2001). Extracts of the study materials were
prepared and placed in contact with a L929 cells mono-
layer. Brieﬂy, the extracts were obtained after 24 h incuba-
tion of the hydrogels in complete culture medium at 37 C
and under constant agitation (60 rpm). The ratio of the
hydrogel to the extract ﬂuid was 3 cm2/ml and the L929
cell-seeding density was 4103 cells/well plate. In all
cytotoxicity tests performed, latex rubber was used as
the positive control for cell death and standard tissue cul-
ture polystyrene was used as a negative control. The
objective of the extraction test was to evaluate changes
in cell morphology and growth inhibition, whereas the
MTS (CellTiter 96W Aqueous One Solution Cell Prolifera-
tion Assay, G3580, Promega) test determines whether
cells are metabolically active (Salgado et al., 2004). The
optical density (OD) was read at 490 nm on a multiwell
microplate reader (Synergie Ht Izasa, Bio-Tek Instruments)
and all cytotoxicity screening tests used six replicates.
2.3.2. Human adipose-derived stem cells
isolation and expansion
Human liposuction aspirate samples were obtained fol-
lowing informed consent from donors undergoing lipoas-
piration procedures under a protocol established with
the Department of Plastic Surgery of the Hospital da
Prelada, Porto, and approved by the local Ethical Committee.
All the samples were processed within 24h after collection.
Human adipose-derived stem cells (hASCs) were enzymati-
cally isolated as previously described (Rada et al., 2010).
Brieﬂy, the adipose tissue samples were digested with 0.2%
collagenase type II (Sigma) in PBS for 45min at 37 C under
gentle stirring. The digested tissue was ﬁltered with a
100mm ﬁlter mesh (Sigma) centrifuged at 1200 rpm for
10min at 20 C, and the cell suspension solution washed
for 5min with lysis buffer to remove erythrocytes. The cells
were again centrifuged and the supernatant removed and
resuspended in a-minimal essential medium (a-MEM;
Gibco) with 10% FBS (Gibco; heat-inactivated), 1% antibi-
otic–antimycotic (Invitrogen) and sodium bicarbonate
(NaHCO3; Sigma). Human ASCs were plated at a density
of 3.5103 cells/cm2 and incubated at 37 C in a humidiﬁed
atmosphere of 5% CO2. The unattached cells were removed
after 2–3days with repeated PBS washings. The adherent
hASCs were cultured with medium changes every 3days.
Conﬂuent cultures were passaged with 0.05% trypsin
(Invitrogen). The enzymatic treatment was quenched in
the presence of FBS and cell counts were done using a
haemocytometer. Only passage 3 (P3) hASCs were used in
the experiments.
For the cell culture experiments, adipose-derived stem
cells were isolated from one patient (a women aged
31 years) and cryopreserved at passage 1, to avoid patient
cells variability. Afterwards, the cells were expanded and
used until P3, performing three independent experiments
using the same batch of cells, with the same passage. The
phenotype of hASCs has been extensively investigated in
previous studies, using tissue sample from the same
anatomical site (subcutaneous), harvested with a similar
technique (such as lipoaspiration) and isolated following
similar procedures (digestion with collagenase) by
Zuk et al. (2002) and Gimble et al. (2007) and also
by our research group (Carvalho et al., 2011a, 2011b;
Rada et al., 2011).
2.3.3. Encapsulation of hASCs in k-carrageenan
hydrogels and in vitro cell culture
k-Carrageenan aqueous dispersions were prepared just
before use by dissolving the biopolymer in distilled water
and then sterilizing, as described in previous section.
Human ASCs were detached by trypsin and centrifuged
at 200 g for 7min. The cells were resuspended in sterile
PBS solution, counted using a haemocytometer and ﬁnally
centrifuged. The supernatant was discarded and k-carra-
geenan 1.5% w/v solution was added to the cells to obtain
a ﬁnal concentration of 5106 cells/ml. The mixture was
resuspended for complete homogenization of the cells
within the matrix. Hydrogel samples containing human
ASCs were prepared using sterile cylindrical moulds and
allowing to rest at room temperature for 1–2min to form a
solid gel. Discs of 5 0.01mm diameter and 2.5 0.46mm
height were cut using a sterile blade. The discs with encapsu-
lated cells were cultured in either basal or chondrogenic
differentiation medium for 1, 7, 14 and 21days, with the me-
dium replaced every 3–4days. Additional controls consisted
of k-carrageenan hydrogel samples without cells, kept under
the same culture conditions for the selected time periods.
The chondrogenic differentiation medium was composed of
low-glucose DMEM (Sigma) supplemented with 10% FBS
(Gibco), 1% antibiotic–antimycotic (Gibco), ITS+1 Liquid
Media Supplement (I2521; insulin–transferrin–selenium
liquid media supplement, Sigma), 17mML-ascorbic acid
(Sigma), 0.1M sodium pyruvate (Sigma), 35mML-proline
(Sigma), 1mM dexamethasone (Sigma) and 10ng/ml
human transforming growth factor-b1 (TGFb1; eBioscience).
2.4. k-Carrageenan hydrogel biological
characterization
2.4.1. Cell viability and proliferation assessment
At the end of each time point of the study, the k-carrageenan
samples with encapsulated hASCs were collected from the
culture plates and incubated in a Calcein AM (Invitrogen)
solution of 1/1000 in culture medium for 15–30min at
37 C and afterwards washed in sterile PBS. The stained
samples were placed on a microscope slide and observed
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under ﬂuorescent microscopy (reﬂected/transmitted light
microscope; Zeiss). The proliferation of the hASCs encapsu-
lated in the k-carrageenan hydrogels was assessed using
a ﬂuorimetric double-strand DNA quantiﬁcation kit
(PicoGreen, Molecular Probes). For this purpose, samples
collected at 1, 7, 14 and 21days of culture were washed in
PBS and then transferred into 1.5ml microtubes containing
1ml ultrapure water. Prior to dsDNA quantiﬁcation, hASC–
hydrogel constructs and the sample controls (hydrogel
samples without cells) were sonicated for 15min to release
all DNA from the hydrogel. Samples and standards
(0–2mg/ml) were prepared and mixed with a PicoGreen
solution in a 200:1 ratio and added to a 96-well opaque
white plate. For each study material and standard, three
samples were used for DNA assays, and triplicates of each
sample were measured; the procedure followed can be
found elsewhere (Labarca and Paigen,1980) andwas based
on themanufacturer’s instructions. The plate was incubated
for 10min in the dark and ﬂuorescence was measured on a
microplate ELISA reader (Bio-Tek, Synergie HT) with an
excitation of 485/20nm and an emission of 528/20nm. A
standard curve was created, and sample DNA values were
read from the standard graph.
2.4.2. Histological analysis
Samples were collected at the end of the experiment
(21 days of culture) ﬁxed, dehydrated with a Spin Tissue
Processor (Microm STP120 Inopat) and embedded in par-
afﬁn using an embedding centre (Microm EC350-1/
EC350-2 Inopat). Sections were cut at 4 mm with a micro-
tome (Microm HM355S Inopat) and placed on micros-
copy slides. Alcian blue (Sigma), safranin O (Sigma),
toluidine blue (Sigma) and haematoxylin and eosin
(H&E; Sigma) stainings were performed using the Auto-
matic Stainer equipment (Microm HMS740 Inopat). Alcian
blue, safranin O and toluidine blue were used to evaluate
cartilage ECM components (glycosaminoglycans) deposi-
tion. Alcian blue staining was performed by rinsing the sec-
tions in 3% acetic acid (Sigma) and incubating them in 1%
alcian blue solution for 30min. After that, the stain was
poured off and the sections counterstained with aqueous
neutral red (Sigma) for 1min, then dehydrated. Safranin
O staining consisted of staining the sections with Weigert’s
iron haematoxylin working solution for 7min, fast green
(Sigma) for 5min and 0.1% safranin O for 5min. The sec-
tions were washed after each staining step, left to dry in air
and then rinsed in absolute alcohol. Toluidine blue staining
solution was prepared by dissolving 1% toluidine blue in
distilled water containing 0.5 g sodium borate (Riedel-
de-Haën), followed by ﬁltering, and the sections were
dipped in for 2–3 s. For H&E staining, after hydration
the sample sections were coloured with Papanicolaou
Harris haematoxylin (Bio-optica) for 3min, washed in
running tap water and afterwards a blue stain enhance-
ment was performed by immersion in 0.5% ammonia
(Sigma) for 5–10 s. The sections were then washed in
running tap water and stained in eosin-Y (Bio-optica)
for 30 s. Finally all slides were dehydrated by immersion
in a series of alcohols (30–100%). The ﬁnal step for
all stainings was immersion in the clearing agent
HistoclearW (National Diagnostics) or xylene substitute
for 1–2min, then mounting using Microscopy EntellanW
(Merck) for later observation. The stained sections were
observed under a light microscope (reﬂected/transmit-
ted light microscope; Zeiss).
2.4.3. Immunohistochemical analysis
Sections of samples corresponding to all experimental
conditions were obtained as described above. Before
removing the parafﬁn the slides were warmed, and anti-
gen retrieval was performed for 20min at 95 C using
10mM citrate buffer. The sections were washed in PBS
for 10–15min and endogenous peroxidase activity was
quenched with 3% hydrogen peroxide (Sigma) in 50%
methanol/tap water for 5min. Afterwards, the samples
were washed with PBS and blocked with 3% bovine
serum albumin (BSA; Sigma) for 1 h to avoid non-speciﬁc
staining. The sections were further incubated with primary
antibodies [collagen types I and II; mouse antitype II colla-
gen (MAB1330) andmouse antitype I collagen (MAB3391);
Chemicon) overnight at 4 C in a humidiﬁed atmosphere.
Then the slides were washed with PBS for 10min and incu-
bated with secondary antibody from a Vectastain Elite ABC
Kit (Vector Laboratories, Peterborough, UK) for 1 h at room
temperature, again in a humidiﬁed atmosphere. The remain-
ing protocol was performed according to that described in
the in the Vector DAB Kit (Vector Laboratories). The slides
were washed in water for 5min and then counterstained
with haematoxylin for nuclei visualization, and ﬁnally
mounted. Controls were performed using normal horse
serum replacing the primary antibodies, which was also
included in the kit. The samples were visualized under
a light microscope and images obtained using a camera
(Axion MRc5, Zeiss).
2.4.4. RNA isolation and real-time quantitative
RT–PCR
Real-time qRT–PCR analysis was used to assess the
expression proﬁle of typical markers for chondrogenic
differentiation, namely Sox9, Aggrecan, Collagen X,
Collagen type I and Collagen type II, and thereby to evalu-
ate the ability of hASCs to undergo differentiation when
encapsulated in k-carrageenan and cultured with either
basal or chondrogenic medium. For this purpose, total
RNA was extracted from cell–hydrogel constructs using
TRI ReagentW RNA Isolation Reagent (Sigma) according
to the technical data sheet provided. Brieﬂy, three sam-
ples of each condition were collected at deﬁned time per-
iods, washed twice with PBS, added to 800 ml TRI Reagent
and vigorously mixed for 10 s, then stored at –80 C until
the analysis was performed. At this point, 160 ml chloro-
form was added and the samples incubated on ice for
15min and centrifuged at 13 000 rpm for 15min at 4 C
to establish a three-phase composition in the tube. The
aqueous phase was collected into new, clean, prechilled
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tubes, where 400 ml ice-cold isopropanol was added, and
the samples were incubated at –20 C overnight. The
samples were then centrifuged at 13 000 rpm for 15min
at 4 C, the supernatant discarded and the pellet washed
with 70% ethanol. After a ﬁnal centrifugation, the sam-
ples were allowed to dry in air and suspended in ultrapure
water for posterior analysis. Each pellet was dissolved in
15ml RNase-free water and kept at –80 C until use. The
amount of isolated RNA and A260/280 nm ratio were quan-
tiﬁed using a Nanodrop ND-1000 spectrophotometer
(Bonsai 06/2008 NanoDrop Technologies, Wilmington,
DE, USA). After these determinations, 2 mg RNA of each
sample was reverse-transcribed using a qScript™ cDNA
Synthesis Kit (Quanta Biosciences) in a 40 ml reaction,
using a MJ Mini™ Personal Thermal Cycler (Bio-Rad
Laboratories) machine. Real-Time qRT–PCR was performed
to detect ampliﬁcation variations, using PerfeCTaW
SYBRW Green FastMixW (Quanta Biosciences) on an
Eppendorf MastercyclerW ep realplex gradient S machine.
The analysis of the results was performed with realplex
software (Eppendorf Mastercycler, Applied Biosystems).
The reaction composition was as follows: 10ml SYBR Green
PCR FastMix, 2.5ml each forward and reverse primer
(see Table 1) and 5ml diluted template with RNase-free
water. The number of cycles and annealing temperature
were selected according to the manufacturer’s instructions.
All the primer sequences were generated using Primer3
software v 0.4.0 and acquired from Euroﬁns MWG Operon
(Ebersberg). More details can be found in Table 1. Each
gene was processed in triplicate. Human ASCs encapsu-
lated in k-carrageenan hydrogel cultured in basal medium
were used as control cell sample. In each sample the mRNA
level expression of each gene was normalized to the
average expression of GAPDH value. The relative gene
expression quantiﬁcation was performed using the 2–ΔCT
and 2–ΔΔCT methods (Livak and Schmittgen, 2001). Three
samples of each material/conditions under study were
analysed.
2.4.5. Mechanical properties of k-carrageenan
hydrogels with encapsulated hASCs
Dynamic mechanical analysis (DMA; Tritec 2000 Triton)
was conducted to characterize the mechanical properties,
under compression loading, of k-carrageenan hydrogel
samples and hydrogels samples with encapsulated hASCs,
after culture in either chondrogenic or basal medium for
different time points. The samples were prepared, as
described above, into discs of 8 0.01mm diameter and
2.5 0.38mm height. The study samples (n= 5) were
subjected to compression cycles of increasing frequency
in the range 0.1–10Hz, with constant amplitude displace-
ments of 0.1mm, using DMA equipment (Triton Technol-
ogy, Nottinghamshire, UK). Experiments were performed
under simulated physiological conditions at 37 C in PBS
medium. The frequency scans, with acquisitions of 15
points/decade, were performed at 37 C with a heating
rate of 2 C/min. The mechanical analysis results were
presented in terms of two main parameters: storage mod-
ulus (E0; the in-phase, elastic component) and loss modu-
lus (E00; the out-of-phase, viscous component). The values
for the compression modulus were collected at a fre-
quency of 0.1–10Hz along the 21 days of culture, and
damping factor was expressed for samples cultured in
chondrogenic medium.
2.5. Statistical analysis
Data obtained from DNA and real-time qRT–PCR analysis
are presented as mean standard deviations (SD; n= 3).
First, a Shapiro–Wilk test was used to ascertain the data
normality. DMA data were ﬁrst inspected with an F-test
for treatments, to determine equality of variance (Liski,
2009). The results indicated that at the 0.05 level, the
data were signiﬁcantly drawn from a normally distributed
population, and one-way ANOVA followed by Tukey test
was used to determine signiﬁcant differences between
groups and conditions, using with OriginPro 8 program.
3. Results and discussion
3.1. Swelling kinetics of k-carrageenan hydrogel
The k-carrageenan hydrogels were obtained by a mild cross-
linking reaction with K+ ions at a stable physiological pH.
The inﬂuence of phosphate buffer solution pH on the swell-
ing properties of k-carrageenan hydrogels was analysed,
determining the equilibrium swelling at pH 1, 4, 7.4 and 11
as a function of time (Figure 1). These results showed that
swelling increases with time, reaching a constant maximum
Table 1. List of genes under evaluation, primers and annealing temperatures used in the analysis of samples corresponding to en-
capsulated hASCs in k-carrageenan and cultured in vitro for different time points
Target gene1 Forward sequence Reverse sequence Tm (C)
SOX9 50-tacgactacaccgaccacca-30 50-ttaggatcatctcggccatc-30 58.4
Aggrecan 50-tgagtcctcaagcctcctgt-30 50-tggtctgcagcagttgattc-30 58.4
Collagen X 50-ccaggtctcgatggtcctaa-30 50-gtcctccaactccaggatca-30 59.4
Collagen I 50-catctccccttcgtttttga-30 50-ccaaatccgatgtttctgct-30 55.3
Collagen II 50-gacaatctggctcccaac-30 50-acagtcttgccccacttac-30 56.4
GAPDH 50-acagtcagccgcatcttctt-30 50-acgaccaaatccgttgactc-30 57.3
1Real-time qRT–PCR thermal cycles correspond to the following periods: 2min at 95 C (hot start), followed by 45 cycles of 95 C for 30 s,
corresponding annealing temperature (noted in the table) for 30 s and an extension step at 68 C for 30 s. A melting curve of 21min and a
hold step at 5 C was performed at the end.
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value after 48h. In general, it was observed that the swelling
ratio increasedwith increasing pH values of the PBS solution,
except for pH 11, which registered the lowest value for the
ﬁrst 28h post-immersion. The amount of water absorbed
during the ﬁrst 7h in PBS at pH 7.4 registered the highest
values, showing that the developed hydrogels exhibit the
highest water uptake at physiological pH. The swelling kinet-
ics of k-carrageenan hydrogels were also investigated when
immersed in cell culture medium (DMEM, pH 7.4, at 37 C)
supplemented with 10% serum (FBS) and compared with
PBS (pH 7.4, at 37 C), as the hydrogels will eventually be
exposed to this medium during cell encapsulation and cul-
ture (Figure 1). It could be observed that the swelling ratio
in DMEM/10% FBSmediumwas lower than in PBS solution.
It is known that, upon implantation of a biomaterial in
the body, a response typically occurs that is characterized
by a decrease in the local pH. Thus, it was thought it
would be important to know the behaviour of the hydro-
gel at various pHs in order to predict and eventually tailor
its response upon implantation, envisioning in vivo studies
and possible future clinical applications. When increasing
the pH values of the immersion solutions from 1 to values
equal to the physiological pH, a signiﬁcant increase of
swelling ratio leading to high water absorption was
observed (Figure 1). The k-carrageenan hydrogels soaked
in medium at pH 11 presented lower water uptake,
revealing that the equilibrium swelling was dependent
upon pH and the ionic composition of the immersion
media. As the pH of the PBS solution was> 4, the ioniza-
tion of the sulphated groups of k-carrageenan gel
occurred and led to ionic repulsion. This resulted in a
more hydrophilic polymer network and contributed to
higher water absorption. In summary, the swelling results
demonstrated that the hydrogels exhibited a pH-dependent
pattern in the range of pH studied. Furthermore, these
results support that the amount of ions present in the
medium signiﬁcantly affects the swelling properties of the
hydrogels, as conﬁrmed by the different results obtained
upon immersion in PBS and DMEM media (Naim et al.,
2004). It is important to note that ionically crosslinked
k-carrageenan loses stability over time in vitro, most
probably due to an outward ﬂux of crosslinking ions into
the surrounding medium (Shoichet et al., 1996).
3.2. Cytotoxicity assessment
The cell behaviour of hydrogel extracts was studied as a
preliminary approach to testing the in vitro toxicity of
the developed k-carrageenan hydrogels. The cytotoxicity
of k-carrageenan hydrogels was evaluated by culturing
L929 cells for 1 and 3 days with extracts of the developed
material. Figure 2 shows the results of cell metabolic
Figure 1. Equilibrium swelling ratio of k-carrageenan hydrogels as a function of time, registered after immersion in PBS solution at
different pH (1, 4, 7.4, 11) and after immersion in DMEM/10% FBS at pH 7.4 and 37 C. Values reported as averages (n=3)SD
Figure 2. Graphical representation of L929 cells metabolic activ-
ity after incubation with extracts of 1.5% w/v k-carrageenan
hydrogel, TCP (negative control) and latex (positive control)
evaluated by MTS assay. *Signiﬁcantly higher metabolic activity
at day 3 as compared to values obtained at day 1 of culture.
Statistical analyses were conducted using one-way ANOVA for
n=6 and error bars represent meanSD
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activity assessed by the MTS test performed with hydrogel
extracts. It can be observed that the viability levels were
similar to the values obtained for the negative control
(TCPs), evidencing that k-carrageenan and possible
leachable products did not exert any cytotoxicity effect
on L929 cells. A signiﬁcant increase in cell viability
was observed from day 1 to the last time point of the assay
(*p< 0.05). The cytotoxicity assessment of k-carrageenan
extracts was carried out as a preliminary approach to
assessing the potentially harmful effect of the developed
hydrogels. The cytotoxicity results (Figure 2) indicated
that the cells were viable in the presence of hydrogel
extracts for all the time points assessed. The cells in
contact with the hydrogel extracts recorded levels of
metabolic activity similar to those which were in contact
with culture medium, showing extremely low cytotoxicity
levels, even after long exposure.
3.3. Fluorescence staining and DNA
quantiﬁcation
Fluorescence staining was conducted to analyse the
viability of the cells after encapsulation/culture on 1.5%
w/v k-carrageenan hydrogels (Figure 3A). Calcein AM
conﬁrmed the viability of hASCs after in vitro culture,
establishing that the cells were viable and homogeneously
distributed inside the hydrogels. Three weeks post-
encapsulation, a high density of cells was observed and
the cells were viable, exhibiting a round shape within the
hydrogel matrix. These results conﬁrmed that the
temperature cycle used to promote the sol–gel transition
of k-carrageenan did not affect cell viability.
Complementary to the viability analysis along the
course of the experiment, the cell content was quantiﬁed
based on dsDNA quantiﬁcation (Figure 3B). Analysis of
obtained DNA values conﬁrmed that from day 1 to day 7
the cell number slightly decreased for the two conditions,
followed by a signiﬁcant increase from day 14 to day 21
(*p< 0.05 for basal medium and **p< 0.05 for chondro-
genic medium). These results are also in agreement with
the ﬂuorescence viability assay (Figure 3A), showing that
the k-carrageenan hydrogel enables the viability and
proliferation of encapsulated hASCs.
An important aspect for hydrogels intended for use as
cell carriers is how the encapsulation process affects the
target cells. These hydrogels have been used to encapsu-
late enzymes, proteins or drugs and then release them
through dissolution of the hydrogel structure (Baeza
et al., 2002; Spagnuolo et al., 2005; Prakash and Martoni,
Figure 3. Viability and proliferation of human adipose stem cells (hASCs) encapsulated in k-carrageenan hydrogels and cultured for
different time points in basal and chondrogenic medium. Fluorescent images (Calcein AM staining) showing the viability and distribution
of encapsulated hASCs after 21days of culture;magniﬁcation=5,with 100mmscale bar (A). Proliferation of hASCs cultured in basal and
chondrogenic medium, results based on DNA test performed after 1, 7, 14 and 21days of culture (B). Error bars represent meanSD. Cell
number is statistically signiﬁcantly higher at 21days than at 14days for both basal and chondrogenic conditions (p<0.05).
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2006), but the use of k-carrageenan for cell delivery is still
poorly exploited in the literature. It seemed that a signiﬁ-
cant drop in cell proliferation from the initial time could
be noticed and this behaviour could be due to the fact that
cells were being released from the cell-loaded hydrogel
systems during culture time, owing to degradation of the
hydrogels. Gelation of k-carrageenan hydrogel was
induced by KCl treatment, which might initially have
affected cell viability, since for fast hydrogel formation a
high KCl concentration was used and the remaining KCl
may have inﬂuenced viability. Moreover, decreased cell
viability upon cell encapsulation in hydrogels is a quite
common ﬁnding, conﬁrmed in several studies reported
in literature (Awad et al., 2004; Marsich et al., 2008;
Wei et al., 2008).
From the DNA assay data (Figure 3B), it was possible to
conﬁrm that until day 14 of culture the different culture
conditions induced signiﬁcant changes in the proliferation
of hASCs. Usually stem cell proliferation decreases when
the differentiation process is activated; thus, the decrease
in cell content could be attributed to this characteristic.
The results obtained regarding the rate of proliferation
of the hASCs cells during the period when they were
submitted to chondrogenic differentiation medium indicate
that from day 14 to day 21 of culture, the cell proliferation
rate increased signiﬁcantly (**p< 0.05). Furthermore,
hydrogels loaded with hASCs cultured in basal medium
presented signiﬁcantly lower proliferation than hASCs
cultured in chondrogenic differentiation medium. Simi-
lar studies using other hydrogels, such as collagen, algi-
nate or agarose, using either BMSCs (Bosnakovski
et al., 2006) or ASCs (Awad et al., 2004), showed similar
cell behaviour. Together, these results indicate that
k-carrageenan enables the viability and proliferation of
encapsulated human ASCs. The chemical composition of
k-carrageenan hydrogels, similar to that of the native
ECM, directly affects the water content of the developed
carriers, which is expected to support the phenotype of
chondrocytes.
In this study hASCs were encapsulated, given that they
are of particular interest for ease of harvest and their po-
tential in therapies to promote cartilage repair, and since
there are numerous studies demonstrating that cells iso-
lated from fat tissue can undergo chondrogenic differenti-
ation when cultured in adequate in vitro conditions (Jung
et al., 2009; Guilak et al., 2010). Studies indicated that
bone marrow-derived MSCs exhibit better chondrogenesis
than MSCs of adipose origin, but advantages such as high
availability and high cell number makes adipose tissue
a highly advantageous stem cell source to work with
(Aﬁzah et al., 2007).
3.4. H&E, alcian blue, safranin-O and toluidine
blue staining
Chondrogenesis occurring in the hASCs laden hydrogels
can be proved by the detection of GAGs deposition
and proteoglycans protein production (Figure 4) with
metachromatic staining for alcian blue, safranin O and
toluidine blue. Figure 4 depicts the positive staining of
hASCs encapsulated in k-carrageenan for alcian blue,
safranin-O and toluidine blue staining, demonstrating
starting deposition of proteoglycans (GAGs), which is
commonly found in native articular cartilage ECM. The
staining with alcian blue (Figure 4A–D) indicated a
concentration of acidic sulphated proteoglycans, and the
cells appeared round within lacunae, which is a distinct
morphological appearance and structural characteristic
speciﬁc to cartilage. For safranin O staining, we could note
the similarity in the intensity of the colour between the
nucleus and cytoplasmic substance for the initial period
of culture, and the difference in colour between these
two for later days in culture (Figure 4E–H). An increase
in the intensity of the staining that evolved from a more
orthochromatic (blue) in the initial periods of culture to
a more pronounced metachromatic (purple) staining in
the later periods was noticed for toluidine blue staining
(Figure 4I–L) similarly to mast cells found in connective
tissue. This effect was more evident in the regions where
cell clusters formed in comparison to individual cells pres-
ent in the hydrogels. These results show that k-carrageenan
hydrogel is not only a lading system for the cell but is
supporting the cells’ functionality, namely the chondrogenic
differentiation, mimicking ECM properties observed by the
interaction and cell spreading within the hydrogel. By the
end of the culture time, setting and partial chondrogenesis
is taking place and a longer time in culture promises full
differentiation of the hASCs. k-Carrageenan hydrogels
maintain the chondrocyte phenotype and promote carti-
lage-speciﬁc ECM deposition even without growth factor
stimulation, as subsequently chondrogenic features
were detected in cell-laden hydrogel cultured in basal
medium, indicating that chondrogenic induction was
hydrogel-dependent.
H&E-stained sections (Figure 4M–P) show the typical
tissue morphology; cell nuclei are stained dark blue while
the cytoplasm andECMhave varying degrees of pink staining.
At the end of week 1 of culture it is possible to observe a
homogeneous distribution of cells with a smaller-sized
basophilic nucleus (blue), while in the following weeks
the cells assumed a more rounded morphology with cyto-
plasmic eosinophilic (pink) substance around the nucleus.
3.5. Immunohistochemistry and real-time qRT–PCR
To further evaluate the chondrogenic differentiation of
hASCs encapsulated in 1.5% w/v k-carrageenan hydrogels,
immunohistochemical analysis of speciﬁc proteins, such as
types I and II collagen, was carried out. Figure 5A–D and
E–H show that the cells were positive for collagen types II
and I, respectively, during the studied culture times, and that
the staining intensity increased with increasing length of cul-
ture, particularly for collagen type II. Differences were found
at the histostructural level between the two proteins evalu-
ated, with collagen type I being detected at early culture
times, whereas positive staining for collagen type II was
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detected for the latest culture times. However, chondrogen-
esis is typically a progressive process, from a morphogenetic
phase to a cytodifferentiation phase of development via a
number of precursor stages to the mature chondrocytes
(Lin et al., 2006). Since a heterogeneous population was
used, it was expected to also have positive staining for colla-
gen type I.With time, the cells enlarged and secreted a dense
organization around the nucleus. On close inspection, cells
from 21day culture were spherical in shape with cytoplasmic
depositions. Although most of the cells had retained the
round shape typically expressed by chondrocytes that popu-
late the deeper layers of articular cartilage (Aydelotte and
Kuettner, 1988), cells lying closer to the surface were ﬂat-
tened. No positive labellingwas found in the negative control
sections, given the absence of the key protein markers
(Figure 5I–L). The presence of a metachromatic-staining
matrix, the chondrocyte-like appearance of the cells and
the detection of type II collagen suggest that the tissue gener-
ated by these cells is similar to native cartilage.
The chondrogenic differentiation of encapsulated hASCs
was additionally evidenced by the results obtained from
real-time qRT–PCR analysis, which allowed assessment of
the expression, at a molecular level, of several important
typical chondrogenic markers for hASCS encapsulated in
k-carrageenan hydrogels (Figure 6). Sustained gene expres-
sion levels were registered for Sox9 (*p< 0.05) andAggrecan
(#p< 0.05), increasing signiﬁcantly with time from day
14 until the end of the experiment. Actually, Sox9was upre-
gulated to values close to 30-fold from day 1 to day 21.
Collagen type II and Aggrecan are considered to be the two
major and most important constituents of hyaline cartilage
ECM, since the functionality of this tissue relies mostly on
the presence of these components (Figure 6). Collagen type
II gene expression decreased fromday 7 to day 14 of culture,
but was signiﬁcantly increased from day 14 to day 21
(**p< 0.05). The expression of Collagen type I, unlike
Collagen type II, registered a two-fold increase between days
7 and 21 of culture (&p< 0.05). At the end of culture it was
possible to notice that high mRNA expression of Sox9
remained, as well as gene expression of Aggrecan and of
Collagen type II. It might be mentioned that Collagen type
X, related to the hypertrophic stage of chondrogenic differ-
entiation, registered a slightly increased expression over
the culture time studied. In general, from the analysis of
gene expression after 3weeks of culture, different stages
in the cell life cycle could be distinguished. Several studies
reported in the literature (Mueller et al., 2010; Zscharnack
et al., 2010), investigating the chondrogenic differentiation
Figure 4. Optical microscopy images of histological sections obtained from k-carrageenan hydrogels with encapsulated hASCs, col-
lected after several periods of culture and stained with alcian blue (A–D), safranin O (E–H), toluidine blue (I–L) and H&E (M–P). Scale
bar=100mm; magniﬁcation=40
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of stem cells, state that chondrogenesis starts around day
14, when the cells start to express chondrogenic markers,
as we also reported in this study. The time-frame of the
study, namely 21days of culture, was selected based on
previous studies, with similar aims, using encapsulated
stem cells in hydrogel for chondrogenic differentiation
(Bosnakovski et al., 2006; Hwang et al., 2006; Zheng
et al., 2009). Although it would be interesting to verify the
outcomes in a long-term experiment, envisioning the
clinical application of the proposed strategy, we were
mostly concerned with the ability of the hydrogels
to guarantee early predifferentiation, as a long-term
in vitro culture before implantation is not interesting in a
clinical/industrial scenario.
Sox9 gene expression was prematurely upregulated,
which indicates the early onset of chondrogenesis (Ahmed
et al., 2007). Sox9 is an important regulator of the chondro-
cyte phenotype (de Crombrugghe et al., 2000) and controls
the expression of Collagen II, a well known marker of the
ECM of cartilage, which is usually expressed in the end-stage
of the chondrogenic process of differentiation (Goldring
et al., 2006). In this system, hASCs were likely stimulated
down the chondrogenic pathway by the growth factor
TGFb1 present in the chondrogenic medium. These ﬁndings
indicated that hASCs can be successfully differentiated into
chondrocytes when encapsulated in k-carrageenan.
3.6. Dynamic mechanical analysis (DMA)
The compressive modulus is a particularly important
parameter to consider in cartilage tissue engineering, as
native cartilage is subjected to movement (i.e. walking,
running); loading and unloading are transient events
occurring in< 1 s. Hence, the mechanical response of car-
tilage should be measured under dynamic cyclic condi-
tions at a functionally relevant frequency, i.e. in the range
Figure 5. Light microscopy images obtained from immunohistochemical staining of hASCS encapsulated in k-carrageenan hydrogels
after 21days of culture for collagen type II (A–D) and type I (E–H) and negative controls (I–L). Scale bar=100mm;magniﬁcation=40
Figure 6. Relative expression of the chondrogenic speciﬁc genes
SOX9, aggrecan, collagen X, collagen type I and collagen type II,
based on the mRNA produced by encapsulated human ASCs after
7, 14 and 21days of culture. The expression of these genes was
normalized against the housekeeping gene GAPDH and calcu-
lated by the ΔCT method. The symbols denote statistically signif-
icant differences between day 14 and day 21 for the following
genes: *, SOX9; **, collagen II; #, aggrecan; 8, collagen X; and
the symbol &, between day 7 and day 21 for collagen I gene.
Statistical analyses were conducted using one-way ANOVA for
n=3; p<0.05. Error bars represent meanSD
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0.5–3Hz (Stolz et al., 2004; Ronken et al., 2012). The
investigation of the viscoelastic properties of biodegradable
hydrogel systems may be of great interest, because one can
not only simulate the physiological dynamical loading but
also access relevant fundamental information at the molec-
ular level, from both a structural and a dynamic perspective
(Oliveira et al., 2005). Moreover, because of its complex
structure and interactions of its biochemical constituents,
and due primarily to ﬂuid ﬂow through the solid matrix,
cartilage behaves mechanically as a viscoelastic solid
(Cohen et al., 1998).
DMA allowed the determination of the mechanical
properties of k-carrageenan hydrogels with encapsulated
hASCs after different culture times (1, 7, 14 and 21days)
in either basal or chondrogenic medium (as compared to
k-carrageenan hydrogels without cells), while immersed
in a PBS solution at 37 C and throughout a physiologi-
cally relevant range of frequencies. Storage (elastic) and
loss (viscous) components of the complex modulus were
determined and are presented in Figure 7. The storage
modulus (E0) curve shows how the stiffness of the poly-
meric material changes with time in culture (Figure 7A).
Figure 7. Storage modulus (E0) obtained from dynamic mechanical analysis upon compression of plain hydrogels and hydrogels with
encapsulated hASCs, cultured in basal and chondrogenic media and tested at a frequency of 1Hz (A). The frequency sweep test
presents the storage modulus in a logarithmic scale at frequencies of 0.1–10Hz of k-carrageenan hydrogels with hASCs cultured in
basal medium (B), hydrogels with hASCs exposed to chondrogenic medium (C) and hydrogels control (D). The damping factor
(tan d) is displayed upon compression over a period of 21days for chondrogenic condition (E). Values reported correspond to an
average of ﬁve test samples (n=5)SD
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At a frequency of 1Hz, the storage modulus of the hydro-
gels was estimated to be 0.23MPa for hASCs in basal
medium, 0.22MPa for cells cultured in chondrogenic
medium and 0.17MPa in k-carrageenan gels alone by
day 21, revealing the elastic nature of these gels. In this
study, the storage modulus (E0) and phase angle or damping
(tan d) were monitored as a function of frequency for the
different hydrogels. The storage modulus curves show how
the stiffness of the polymeric material changed with
frequency (Figure 7B–D). Increase in E0 was observed
for increasing frequencies in the range 0.1–10Hz, which
suggests that the hydrogels exhibited stiffer behaviour
for higher frequencies. With the application of high
frequencies to the hydrogel, the material became glassy
and solid-like; at very low frequencies, the polymer
exhibited a more liquid-like or rubbery response. The
storage modulus of the hydrogel without cells presented
variations between the initial and ﬁnal time points, sug-
gesting that the hydrogels become softer, possibly due
to a loss of the cross-linking ions or to a loss in gel stability
due to thermal factors, as it is a thermoreversible and
ionic hydrogel. The elastic modulus of k-carrageenan
hydrogels was improved with encapsulation of hASCs
and with increasing time in culture (Figure 7A). Similar
behaviour was found for agarose or alginate hydrogels
with the same type of cells and similar culture conditions
(Awad et al., 2004). Nevertheless, k-carrageenan with
encapsulated hASCs exhibits a compression modulus
approximately 10-fold higher than that reported for
agarose and alginate hydrogels in the study by Awad et al.
(2004). Hydrogels also possess damping capability that
may be useful to dissipate cyclic mechanical energy that is
imposed in an implantation scenario. ’Damping’ is the term
used for the general tendency of vibrating materials or
structures to lose some elastic energy to internal heating
or external friction; it tell us how good a material will be
at absorbing energy (Mano et al., 2002). The corresponding
graphs are shown in Figure 7E. An increase in tan d is
observed from 0.1 to 10Hz for day 1 for the chondrogenic
medium condition, suggesting a higher dissipation capa-
bility of k-carrageenan hydrogels at higher frequencies
(Figure 7E). At the beginning of culture we could notice
an increase in tan d values, but after 21 days in culture
we could observe a decrease for increasing frequencies,
which is related to the higher viscous component of
hydrogel biomaterial.
During the 21 days in culture, DMA analysis indicated
an increase in storage modulus and in the viscoelastic
properties of k-carrageenan gels with encapsulated cells,
suggesting an increase in the stiffness possible due to
ECM production. It is believed that the subsequent depo-
sition of ECM components within the gel constructs was
facilitated by the gradual degradation of the gels. At day
21 the statistical analysis indicated that the mean differ-
ence was signiﬁcant at the 0.05 level between the cell-
encapsulating hydrogels compared to the cell-free hydro-
gel control. The mechanism behind the increase in stiffness
of the cell-laden hydrogels likely involves more than the
cell load, as it is a result of cell-mediated interactions
and deposition of matrix with time. In addition, stem
cells can proliferate as well as differentiate, but as cells
differentiate their rate of replication usually decreases,
and by the end of 21 days there is no difference in
terms of elastic modulus values between cells exposed
or not exposed to the differentiation medium. It has
been demonstrated that the biomechanical properties
of articular cartilage greatly depend on composition,
density of ECM and interstitial ﬂuid ﬂow (water and
solutes) (Evans and Quinn, 2005). Cell encapsulation
and ECM deposition may therefore result in progressive
increase of the mechanical properties of the 3D struc-
tures, as shown previously for the cell–hydrogel con-
struct (Miyata et al., 2004).
The characterization at the molecular level correlated
with the mechanical properties developed by these
systems, as at day 14 we observed a decrease in the
Collagen type II chondrogenic marker (responsible for
the tensile properties); at the same time point there is
an upregulation of Aggrecan gene expression (responsi-
ble for the compressive properties of the hydrogel), as
these markers are interacting and are being expressed
differently during chondrogenic differentiation. These
values mimic the mechanical properties found in articu-
lar cartilage and they are higher or within the range of
values found for other hydrogels used in similar carti-
lage-regenerative approaches (Kisiday et al., 2002; Nettles
et al., 2004). Human articular cartilage possesses signiﬁ-
cant mechanical properties, with a compressive modulus
of 0.79MPa, a shear modulus of 0.69MPa and a tensile
modulus of 0.3–10.2MPa (Fisher et al., 2004). Evaluation
of these properties contributed to a further understanding
of the potential of these hydrogels for the target
application.
Considering the suitable mechanical properties,
together with the simplicity and reproducibility of the
preparation process for k-carrageenan hydrogel forma-
tion, which is performed under mild conditions without
employing any extraneous toxic crosslinking agents, it is
possible to conclude that such a matrix has potential
applications in cartilage tissue-engineering applications.
To further enhance the quality of engineered cartilage
tissues formed from encapsulating hASCs within this
system, one may optimize the release rates of supplemen-
tal growth factors incorporated in the hydrogels. It is also
possible that host cells could be recruited to the gel, by
release of the growth factors participating in cartilage
formation.
4. Conclusions
This study presents k-carrageenan as a potential
hydrogel for cell delivery, with application in the regener-
ation of cartilage. In summary, the results obtained using
k-carrageenan hydrogels as a cell-loading matrix, pre-
pared via an ionic crosslinking reaction, demonstrate
that this system could be an alternative cell-delivery
hydrogel system. hASCs encapsulated in k-carrageenan
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hydrogels remain viable, proliferate and differentiate into
the chondrogenic lineage. Furthermore, k-carrageenan
hydrogels with encapsulated hASCs were able to
achieve mechanical properties, under compression, in
the range of those reported for native cartilage. These
promising in vitro results should be further analysed in
animal model experiments designed to address funda-
mental questions concerning the in vivo degradation
of the hydrogel and the possible in vivo differentiation of
encapsulated cells.
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